CN101041009A - 一种治疗咽喉炎的中药药物 - Google Patents
一种治疗咽喉炎的中药药物 Download PDFInfo
- Publication number
- CN101041009A CN101041009A CN 200710055545 CN200710055545A CN101041009A CN 101041009 A CN101041009 A CN 101041009A CN 200710055545 CN200710055545 CN 200710055545 CN 200710055545 A CN200710055545 A CN 200710055545A CN 101041009 A CN101041009 A CN 101041009A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- fructus
- oleum menthae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims description 91
- 150000001875 compounds Chemical class 0.000 title claims description 7
- 244000269722 Thea sinensis Species 0.000 claims abstract description 17
- 235000009569 green tea Nutrition 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 241001530126 Scrophularia Species 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 36
- 241000628997 Flos Species 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 9
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- 239000001116 FEMA 4028 Substances 0.000 claims description 5
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 5
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 5
- 229960004853 betadex Drugs 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 4
- 241000245240 Lonicera Species 0.000 claims description 4
- 241000133222 Lychnophora Species 0.000 claims description 4
- 201000008197 Laryngitis Diseases 0.000 abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000012254 Canarium album Species 0.000 abstract 1
- 235000009103 Canarium album Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 240000005049 Prunus salicina Species 0.000 abstract 1
- 235000021282 Sterculia Nutrition 0.000 abstract 1
- 240000001058 Sterculia urens Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000009018 li Nutrition 0.000 abstract 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 abstract 1
- 235000019477 peppermint oil Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 229940059107 sterculia Drugs 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 24
- 210000003800 pharynx Anatomy 0.000 description 22
- 201000007100 Pharyngitis Diseases 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 210000004072 lung Anatomy 0.000 description 18
- 230000008961 swelling Effects 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 206010068319 Oropharyngeal pain Diseases 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000001629 suppression Effects 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 235000010418 carrageenan Nutrition 0.000 description 6
- 229920001525 carrageenan Polymers 0.000 description 6
- 230000035568 catharsis Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 208000016150 acute pharyngitis Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229960001340 histamine Drugs 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000004856 capillary permeability Effects 0.000 description 4
- 210000004681 ovum Anatomy 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010002953 Aphonia Diseases 0.000 description 3
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 229960004397 cyclophosphamide Drugs 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000005453 pelletization Methods 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 238000002562 urinalysis Methods 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 2
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001347978 Major minor Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- QTENRWWVYAAPBI-YZTFXSNBSA-N Streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O QTENRWWVYAAPBI-YZTFXSNBSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 201000010550 acute laryngitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000009285 allergic inflammation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 201000009243 chronic laryngitis Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002409 epiglottis Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000021245 head disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 235000015091 medicinal tea Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
细菌种类 | 不同药物浓度细菌生长现象 | 氨苄青霉素 | 链球菌 | ||||
原液 | 1∶5 | 1∶10 | 1∶20 | 1∶40 | |||
甲型溶血性链球菌一型溶血性链球菌肺炎球菌表皮葡萄球菌 | ---- | ---- | -+++- | -++++++++ | ++++++++++ | ---- | +--- |
组别 | 鼠数(只) | 耳片重量差(mg) |
对照组复方草珊瑚含片10片/kg袋泡茶12g/kg袋泡茶6g/kg袋泡茶3g/kg | 99999 | 13.4±5.628.7±3.04*3.6±4.92***5.9±2.21**7.4±6.33* |
组别 | 鼠数(只) | 足重量差(mg) |
对照组袋泡茶12g/kg袋泡茶6g/kg袋泡茶3g/kg | 1081010 | 64.5±18.0346.9±12.11*57.6±12.2258.8±14.52 |
组别 | 鼠数(只) | 足重量差(mg) |
对照组袋泡茶12g/kg袋泡茶6g/kg袋泡茶3g/kg | 11101111 | 53.6±12.3033.5±9.72**42.5±10.79*49.6±15.64 |
组别 | 鼠数(只) | 注射角叉菜胶后不同时间(h)足肿胀程度(mm) | |||||
1 | 2 | 3 | 4 | 5 | 6 | ||
对照组袋泡茶12g/kg6g/kg3g/kg | 8677 | 4.9±1.462.9±1.57*3.0±1.63*3.8±0.75 | 2.6±2.003.7±1.11*3.9±1.954.2±1.33 | 8.0±1.606.4±2.708.7±3.597.8±2.48 | 10.3±2.6610.2±2.6211.9±4.5613.2±3.97 | 14.3±2.8213.1±3.8115.9±4.1816.8±4.88 | 14.4±2.9714.6±2.5116.3±2.7517.7±3.88 |
组别 | 鼠数(只) | OD值 |
对照组袋泡茶12g/kg6g/kg3g/kg | 891010 | 0.39±0.3240.13±0.083*0.28±0.2110.16±0.102 |
组别 | 鼠数(只) | 耳片重量差(mg) | 脾重(mg/10g体重) | 肾上腺重(mg/10g体重) |
对照组环磷酰胺100mg/kg袋泡茶6g/kg3g/kg | 9889 | 2.2±1.371.2±1.100.7±0.82**1.1±1.04 | 49.2±17.2017.5±6.20***63.9±24.548.2±8.42 | 3.8±0.963.6±0.794.2±2.154.1±1.28 |
1.5g/kg | 10 | 1.9±1.76 | 61.2±21.67 | 4.5±1.86 |
恶寒 | 0 | 5 | 34 | 111 | 0 | 0 | 3 | 147 | 10.699 | <0.05 |
咳嗽 | 5 | 8 | 38 | 99 | 0 | 0 | 12 | 138 | 16.032 | <0.01 |
食欲不振 | 0 | 9 | 45 | 96 | 0 | 2 | 8 | 140 | 19.255 | <0.01 |
频频求饮 | 5 | 17 | 34 | 94 | 0 | 1 | 8 | 141 | 23.021 | <0.01 |
四肢酸楚 | 2 | 13 | 29 | 106 | 2 | 1 | 6 | 141 | 12.152 | <0.01 |
口臭 | 0 | 4 | 22 | 124 | 0 | 0 | 4 | 156 | 5.156 | >0.05 |
气短懒言 | 0 | 2 | 17 | 131 | 0 | 0 | 3 | 147 | 2.573 | >0.05 |
自汗 | 0 | 2 | 14 | 134 | 0 | 1 | 2 | 147 | 1.673 | >0.05 |
神倦乏力 | 4 | 13 | 64 | 69 | 0 | 2 | 15 | 133 | 42.12 | <0.01 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100555452A CN100553665C (zh) | 2007-04-20 | 2007-04-20 | 一种治疗咽喉炎的中药药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100555452A CN100553665C (zh) | 2007-04-20 | 2007-04-20 | 一种治疗咽喉炎的中药药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101041009A true CN101041009A (zh) | 2007-09-26 |
CN100553665C CN100553665C (zh) | 2009-10-28 |
Family
ID=38806938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100555452A Active CN100553665C (zh) | 2007-04-20 | 2007-04-20 | 一种治疗咽喉炎的中药药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100553665C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101474373B (zh) * | 2009-01-19 | 2011-03-16 | 河南百年康鑫药业有限公司 | 一种治疗急性咽炎的中药 |
CN101284081B (zh) * | 2008-01-03 | 2011-05-18 | 王水梓 | 一种解酒醒酒的药物及其制备方法 |
CN102177998A (zh) * | 2011-03-29 | 2011-09-14 | 刘维祺 | 一种清咽利喉保健茶 |
CN102526488A (zh) * | 2012-03-23 | 2012-07-04 | 临沂大学 | 一种具有清咽功能的中药组合物 |
CN102670957A (zh) * | 2012-03-31 | 2012-09-19 | 东莞市亚洲制药有限公司 | 保健组合物及其制备方法和用途 |
CN103719501A (zh) * | 2014-01-16 | 2014-04-16 | 汤泓 | 一种舒缓鼻咽炎症的调理茶及其制备方法 |
CN105560812A (zh) * | 2016-01-04 | 2016-05-11 | 成都富豪斯生物科技有限公司 | 一种治疗急、慢性咽喉炎的汤剂药物及其制备方法 |
CN105963347A (zh) * | 2016-05-27 | 2016-09-28 | 昆明理工大学 | 一种用于治疗咽喉炎症的中药制剂 |
CN111888413A (zh) * | 2020-09-18 | 2020-11-06 | 天津中医药大学 | 一种用于秋季呼吸道疾病的药物组合物 |
CN114097911A (zh) * | 2021-12-28 | 2022-03-01 | 西南民族大学 | 一种预防和治疗咽炎的袋泡茶及其检测方法 |
-
2007
- 2007-04-20 CN CNB2007100555452A patent/CN100553665C/zh active Active
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101284081B (zh) * | 2008-01-03 | 2011-05-18 | 王水梓 | 一种解酒醒酒的药物及其制备方法 |
CN101474373B (zh) * | 2009-01-19 | 2011-03-16 | 河南百年康鑫药业有限公司 | 一种治疗急性咽炎的中药 |
CN102177998A (zh) * | 2011-03-29 | 2011-09-14 | 刘维祺 | 一种清咽利喉保健茶 |
CN102526488A (zh) * | 2012-03-23 | 2012-07-04 | 临沂大学 | 一种具有清咽功能的中药组合物 |
CN102526488B (zh) * | 2012-03-23 | 2014-02-12 | 临沂大学 | 一种具有清咽功能的中药组合物 |
CN102670957B (zh) * | 2012-03-31 | 2014-10-29 | 东莞市亚洲制药有限公司 | 保健组合物及其制备方法和用途 |
CN102670957A (zh) * | 2012-03-31 | 2012-09-19 | 东莞市亚洲制药有限公司 | 保健组合物及其制备方法和用途 |
CN103719501A (zh) * | 2014-01-16 | 2014-04-16 | 汤泓 | 一种舒缓鼻咽炎症的调理茶及其制备方法 |
CN103719501B (zh) * | 2014-01-16 | 2015-03-25 | 汤泓 | 一种舒缓鼻咽炎症的调理茶及其制备方法 |
CN105560812A (zh) * | 2016-01-04 | 2016-05-11 | 成都富豪斯生物科技有限公司 | 一种治疗急、慢性咽喉炎的汤剂药物及其制备方法 |
CN105963347A (zh) * | 2016-05-27 | 2016-09-28 | 昆明理工大学 | 一种用于治疗咽喉炎症的中药制剂 |
CN111888413A (zh) * | 2020-09-18 | 2020-11-06 | 天津中医药大学 | 一种用于秋季呼吸道疾病的药物组合物 |
CN111888413B (zh) * | 2020-09-18 | 2022-07-12 | 天津中医药大学 | 一种用于秋季呼吸道疾病的药物组合物 |
CN114097911A (zh) * | 2021-12-28 | 2022-03-01 | 西南民族大学 | 一种预防和治疗咽炎的袋泡茶及其检测方法 |
CN114097911B (zh) * | 2021-12-28 | 2023-10-03 | 西南民族大学 | 一种预防和治疗咽炎的袋泡茶及其检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100553665C (zh) | 2009-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101041009A (zh) | 一种治疗咽喉炎的中药药物 | |
CN1739734A (zh) | 治疗口腔炎症的中药制剂及其制备方法 | |
CN1682842A (zh) | 一种消炎解毒的中药组合物及其制备方法和用途 | |
CN1072952C (zh) | 用于治疗慢性咽炎的中药丸剂 | |
CN1221277C (zh) | 一种预防和治疗肺炎、支气管炎、咽炎及上呼吸道感染的药物及其制备方法 | |
CN1403138A (zh) | 一种治疗泌尿系统感染和前列腺炎的中药复方制剂及制备 | |
CN105535495A (zh) | 一种培元固本治疗食管癌的中药组合物及制备方法 | |
CN1293913C (zh) | 一种治疗急慢性咽炎的中药袋泡茶剂及其生产方法 | |
CN1698691A (zh) | 一种治疗肺热(毒)咳嗽的药物及其制备方法 | |
CN1857502A (zh) | 一种用于治疗牙痛的中药搽剂及其制备方法 | |
CN106490268A (zh) | 一种用于解酒毒的茶饮及其制备方法 | |
CN102274428B (zh) | 一种具有治疗肠易激综合症作用的药物组合物及其制备方法和应用 | |
CN1840008A (zh) | 一种能清咽润喉的中药颗粒及其制备方法 | |
CN100344319C (zh) | 治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 | |
CN1244356C (zh) | 一种健脾和胃、消积化滞的药物 | |
CN1088378C (zh) | 治疗慢性浅表性胃炎的中药口服液及其制备方法 | |
CN104491338B (zh) | 一种润肠通便的药食两用组合物及其制备方法 | |
CN103550699B (zh) | 一种治疗各型胃病的中药组合药物 | |
CN105343503A (zh) | 一种治疗咽喉炎的药物组合物及其应用 | |
CN102755461A (zh) | 一种治疗急性咽炎的中药果蔬复合口服液 | |
CN1839882A (zh) | 一种治疗脚癣和体癣的药物组合物 | |
CN104857304B (zh) | 一种组合物在制备治疗胆道蛔虫症的药物中的用途 | |
CN1679908A (zh) | 一种治疗肿瘤的中药及其制备方法 | |
CN104587249B (zh) | 一种具有清肺润燥利咽作用的中药组合物及其制备方法和应用 | |
CN1281706A (zh) | 一种适用于各种癌症的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: XU HUIBO Effective date: 20120606 Owner name: JILIN WANTONG PHARMACY CO., LTD. Free format text: FORMER OWNER: SUN XIAOBO Effective date: 20120606 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130021 CHANGCHUN, JILIN PROVINCE TO: 130012 CHANGCHUN, JILIN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120606 Address after: 130012 No. 598, Xin Xin Street, hi tech Industrial Development Zone, Jilin, Changchun Patentee after: JILIN WANTONG PHARMACY CO., LTD. Address before: 130021, Jilin province Changchun Chaoyang District Long Li Jiayuan C block 2 door 501 rooms Co-patentee before: Xu Huibo Patentee before: Sun Xiaobo |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070926 Assignee: Tonghua Wantong Pharmaceutical Co., Ltd. Assignor: JILIN WANTONG PHARMACY CO., LTD. Contract record no.: 2014220000011 Denomination of invention: Chinese traditional medicine compound for treating faucitis Granted publication date: 20091028 License type: Exclusive License Record date: 20140225 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Tonghua Wantong Pharmaceutical Co., Ltd. Assignor: JILIN WANTONG PHARMACY CO., LTD. Contract record no.: 2014220000011 Date of cancellation: 20141014 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |